These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

94 related items for PubMed ID: 7739123

  • 21. Evaluation of commercial HTLV-1 test kits by a standard HTLV-1 serum panel.
    Fujiyama C, Fujiyoshi T, Matsumoto D, Tamashiro H, Sonoda S.
    Bull World Health Organ; 1995; 73(4):515-21. PubMed ID: 7554024
    [Abstract] [Full Text] [Related]

  • 22. Simple assay system for detecting human T cell leukemia virus type I-binding cells and its application in titrating binding inhibitory antibodies.
    Akari H, Kannagi M, Shinjo T, Harada S.
    Lab Invest; 1993 Nov; 69(5):629-34. PubMed ID: 8246453
    [Abstract] [Full Text] [Related]

  • 23. Evaluation of HTLV-I/II infection in blood donors in Buenos Aires.
    Gutfraind Z, Blejer JL, Saguier MC, Gómez Carretero ML, Pirola DA, Carreras Vescio LA.
    Medicina (B Aires); 1995 Nov; 55(4):295-9. PubMed ID: 8728867
    [Abstract] [Full Text] [Related]

  • 24. Particle agglutination test "Serodia HIV-1/2" as a novel anti-HIV-1/2 screening test: comparative study on 3311 serum samples.
    Poljak M, Zener N, Seme K, Kristancic L.
    Folia Biol (Praha); 1997 Nov; 43(4):171-3. PubMed ID: 9338125
    [Abstract] [Full Text] [Related]

  • 25. Prevalence of human T-cell leukemia virus type 1 (HTLV-I) in adult T-cell leukemia (ATL) in non-ATL-endemic Hokkaido of Japan.
    Iwanaga M, Takada K, Fujiwara S, Oikawa O, Sugiura M, Imai S, Osato T, Mikuni C, Maekawa I, Miyazaki T.
    In Vivo; 1994 Nov; 8(6):1007-10. PubMed ID: 7772727
    [Abstract] [Full Text] [Related]

  • 26. Preliminary survey of anti-HTLV-I in northeastern-Thais.
    Burusrux S, Urwijitaroon Y, Romphruk A, Puapairoj C.
    J Med Assoc Thai; 1995 Nov; 78(11):628-30. PubMed ID: 8576676
    [Abstract] [Full Text] [Related]

  • 27. Unusual finding of HTLV-I infection among Amazonian Amerindians.
    Barros Kanzaki LI, Casseb J.
    Arch Med Res; 2007 Nov; 38(8):897-900. PubMed ID: 17923274
    [Abstract] [Full Text] [Related]

  • 28. Evaluation of the human T-cell leukemia virus type I seropositivity of blood donors by the particle agglutination inhibition test.
    Kwon KW, Ikeda H, Yano M, Sekiguchi S.
    Jpn J Cancer Res; 1989 Sep; 80(9):833-9. PubMed ID: 2513300
    [Abstract] [Full Text] [Related]

  • 29. Ocular manifestations in patients with HTLV-I associated infection--a clinical study of 93 cases.
    Merle H, Smadja D, Le Hoang P, Bera O, Cabre P, Landau M, Vernant JC.
    Jpn J Ophthalmol; 1996 Sep; 40(2):260-70. PubMed ID: 8876397
    [Abstract] [Full Text] [Related]

  • 30. Prevention of transmission of human T-lymphotropic virus type 1 (HTLV-1) through transfusion, by donor screening with antibody to the virus. One-year experience.
    Inaba S, Sato H, Okochi K, Fukada K, Takakura F, Tokunaga K, Kiyokawa H, Maeda Y.
    Transfusion; 1989 Jan; 29(1):7-11. PubMed ID: 2643213
    [Abstract] [Full Text] [Related]

  • 31. [Screening of antibodies to human T-cell leukemia virus type I (HTLV-I) in sera of blood donors and comparison of different methods].
    Fan FS, Lin DL, Yeh HM, Chen MS, Su JL, Lin SH, Tzeng CH, Chuang MW, Liu JH, Hsieh RK.
    Zhonghua Yi Xue Za Zhi (Taipei); 1989 Jul; 44(1):71-6. PubMed ID: 2684368
    [Abstract] [Full Text] [Related]

  • 32. A comparative evaluation of prevalence of HTLV-1 antibodies in blood donors in Delhi India by PAT and LIA method.
    Singh R, Thomas R.
    J Commun Dis; 2003 Dec; 35(4):263-5. PubMed ID: 15909754
    [Abstract] [Full Text] [Related]

  • 33. Comparison of four commercial screening assays for the diagnosis of human T-cell lymphotropic virus types 1 and 2.
    Berini CA, Susana Pascuccio M, Bautista CT, Gendler SA, Eirin ME, Rodriguez C, Pando MA, Biglione MM.
    J Virol Methods; 2008 Feb; 147(2):322-7. PubMed ID: 17977605
    [Abstract] [Full Text] [Related]

  • 34. HTLV-I serostatus of mothers of patients with adult T-cell leukemia and HTLV-I-associated myelopathy/tropical spastic paraparesis.
    Bartholomew C, Jack N, Edwards J, Charles W, Corbin D, Cleghorn FR, Blattner WA.
    J Hum Virol; 1998 Feb; 1(4):302-5. PubMed ID: 10195256
    [Abstract] [Full Text] [Related]

  • 35. Evaluation of particle agglutination test for detection of HIV-I antibodies.
    Prakash JV, Khare PM, Haridas V.
    Indian J Pathol Microbiol; 1993 Apr; 36(2):138-42. PubMed ID: 8276477
    [Abstract] [Full Text] [Related]

  • 36. HIV-antibody detection in vitreous humor and serum by enzyme immunosorbent assay and particle agglutination test.
    Schor P, Sato EH, Kuroda A, Barros PS, Marcopito LA, Belfort R.
    Cornea; 1997 Sep; 16(5):541-4. PubMed ID: 9294686
    [Abstract] [Full Text] [Related]

  • 37. Detection of antibodies to human T-lymphotropic virus type I by using synthetic peptides.
    Kuroda N, Washitani Y, Shiraki H, Kiyokawa H, Ohno M, Sato H, Maeda Y.
    Int J Cancer; 1990 May 15; 45(5):865-8. PubMed ID: 2185995
    [Abstract] [Full Text] [Related]

  • 38. Differential patterns of serum biomarkers of immune activation in human T-cell lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis, and adult T-cell leukemia/lymphoma.
    Giusti RM, Maloney EM, Hanchard B, Morgan OS, Steinberg SM, Wachter H, Williams E, Cranston B, Fuchs D, Manns A.
    Cancer Epidemiol Biomarkers Prev; 1996 Sep 15; 5(9):699-704. PubMed ID: 8877061
    [Abstract] [Full Text] [Related]

  • 39. Vertical transmission of HTLV-I from a seronegative mother using the PA method.
    Umemoto M, Take H, Kuraya K.
    Acta Paediatr Jpn; 1995 Feb 15; 37(1):68-70. PubMed ID: 7754770
    [Abstract] [Full Text] [Related]

  • 40. A simple and inexpensive particle agglutination test to distinguish recent from established HIV-1 infection.
    Li H, Ketema F, Sill AM, Kreisel KM, Cleghorn FR, Constantine NT.
    Int J Infect Dis; 2007 Sep 15; 11(5):459-65. PubMed ID: 17369067
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.